Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

This article is a companion paper to A. Davies, et al., which is also published in this issue.FundingF. Hoffmann-La Roche Ltd., Basel, Switzerland.

Source: Advances in Therapy - October 5, 2017 Category: Drugs & Pharmacology Source Type: research